EndothelinB (ETB) receptor-activated potentiation of cholinergic nerve-mediated contraction in human bronchus

Br J Pharmacol. 1996 Aug;118(8):1873-4. doi: 10.1111/j.1476-5381.1996.tb15617.x.

Abstract

In human isolated bronchial preparations, the endothelinB (ETB) receptor-selective agonist, sarafotoxin S6c (Stx6c; 1 nM) increased nerve-mediated contraction in response to electrical field stimulation (EFS) at 0.5-1 Hz from 19 +/- 4% to 42 +/- 7% (n = 9). This effect was blocked in the presence of the ETB receptor-selective antagonist, BQ-788 (10 microM). These data are consistent with findings in some animal species that ET-1 and related peptides have marked neuromodulatory influences on the cholinergic system. Furthermore, they provide additional support for the concept that ET-1 may have a mediator role in bronchial obstruction in asthma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Bronchi / drug effects*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Muscle Contraction / drug effects*
  • Oligopeptides / pharmacology
  • Piperidines / pharmacology
  • Receptors, Endothelin / drug effects*
  • Tetrodotoxin / pharmacology
  • Vasoconstrictor Agents / pharmacology
  • Viper Venoms / pharmacology

Substances

  • Oligopeptides
  • Piperidines
  • Receptors, Endothelin
  • Vasoconstrictor Agents
  • Viper Venoms
  • sarafotoxins s6
  • Tetrodotoxin
  • BQ 788